Therapy for Microcirculatory Disorders in Severe Acute Pancreatitis: Effectiveness of Platelet-Activating Factor Receptor Blockade vs. Endothelin Receptor Blockade

Journal of Gastrointestinal Surgery

Volumn 3, Issue 3, 1999, Pages 244-251

  Foitzik, Thomas ^a,c   Hotz, Hubert G ^a   Eibl, Guido ^a   Hotz, Birgit ^a   Kirchengast, Michael ^b   Buhr, Heinz J ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b Knoll AG   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Acute pancreatitis (experimental); Endothelin; Microcirculation; Platelet activating factor; Vasoactive mediators

Indexed keywords

CELL SURFACE RECEPTOR; ENDOTHELIN 1; ENDOTHELIN RECEPTOR; FIBRINOGEN RECEPTOR; G PROTEIN COUPLED RECEPTOR; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR RECEPTOR;

ACUTE HEMORRHAGIC PANCREATITIS; ANIMAL; ARTICLE; ASCITES; BLOOD FLOW; CAPILLARY; CAPILLARY PERMEABILITY; CHI SQUARE DISTRIBUTION; COLON; COMPARATIVE STUDY; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; FLUID THERAPY; HEMATOCRIT; LAPAROTOMY; LEUKOCYTE; MALE; MICROCIRCULATION; PANCREAS; PLEURA EFFUSION; RANDOMIZATION; RAT; SPRAGUE DAWLEY RAT; SURVIVAL RATE; URINE; VASCULARIZATION;

ANIMALS; ASCITES; CAPILLARIES; CAPILLARY PERMEABILITY; CHI-SQUARE DISTRIBUTION; COLON; DISEASE MODELS, ANIMAL; ENDOTHELIN-1; FLUID THERAPY; HEMATOCRIT; LAPAROTOMY; LEUKOCYTES; MALE; MICROCIRCULATION; PANCREAS; PANCREATITIS, ACUTE NECROTIZING; PLATELET ACTIVATING FACTOR; PLATELET MEMBRANE GLYCOPROTEINS; PLEURAL EFFUSION; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CELL SURFACE; RECEPTORS, ENDOTHELIN; RECEPTORS, G-PROTEIN-COUPLED; REGIONAL BLOOD FLOW; SURVIVAL RATE; URINE;

EID: 0033122766     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1091-255X(99)80066-3     Document Type: Article

References (39)

1. Warshaw AL. Ischemia- and reperfusion-related injury in pancreatitis. Dig Dis Sci 1996;41:821-822.
2. Dobosz M, Hac S, Wajda Z. Does nitric oxide protect from microcirculatory disturbances in experimental acute pancreatitis in rats? Int J Microcirc 1996;16:221-226.
3. Yamanaka K, Saluja AK, Brown GE, Yamaguchi Y, Hofbauer B, Steer ML. Protective effects of prostaglandin El on acute lung injury of caerulein-induced acute pancreatitis in rats. Am J Physiol 1997;272:G23-G30.
4. Hotz HG, Foitzik T, Rohweder J, Schulzke JD, Fromm M, Runkel NSF, Buhr HJ. Intestinal microcirculation and gut permeability in acute pancreatitis: Early changes and therapeutic implications. J GASTROINTEST SURG 1998;2:518-525.
5. Kingsnorth A. Role of cytokines and their inhibitors in acute pancreatitis. Gut 1997;40:1-4.
6. Gross V, Leser H-G, Heinisch A, Scölmerich J. Inflammatory mediators and cytokines. New aspects of the pathophysiology and assessment of severity of acute pancreatitis? Hepatogastroenterol 1993;40:522-530.
7. Yotsumoto F, Manabe T, Ohshio G, Imanishi K, Ando T, Kyogoku T, Hirano T, Tobe T. Role of pancreatic blood flow and vasoactive substances in the development of canine acute pancreatitis. J Surg Res 1993;55:531-536.
8. Weidenbach H, Lerch MM, Gress TM, Pfaff D, Turi S, Adler G. Vasoactive mediators and the progression from edematous to necrotizing experimental acute pancreatitis. Gut 1995;37: 434-440.
9. Schmidt J, Rattner DW, Lewandrowski K, Compton CC, Mandavilli U, Knoefel WT, Warshaw AL. A better model of acute pancreatitis for evaluating therapy. Ann Surg 1992;215: 44-56.
10. Foitzik T, Stufler M, Hotz HG, Klinnert J, Wagner J, Warshaw AL, Schulzke JD, Fromm M, Buhr HJ. Glutamine stabilizes intestinal permeability and reduces pancreatic infection in acute experimental pancreatitis. J GASTROINTEST SURG 1997;1:40-47.
11. Foitzik T, Fernandez-del-Castillo C, Ferraro MJ, Mithofer K, Rattner DW, Warshaw AL. Pathogenesis and prevention of early pancreatic infection in experimental acute necrotizing pancreatitis. Ann Surg 1995;222:179-185.
12. Klyscz T, Jünger M, Jung F, Zeind H. Cap Image - ein neuartiges computerunterstütztes Videobildanalysesystem für die dynamische Kapillarmikroskopie. Biomed Technik 1997;42: 168-175.
13. Foitzik T, Faulhaber J, Hotz HG, Kirchengast M, Buhr HJ. Endothelin receptor blockade improves fluid sequestration, pancreatic capillary blood flow and survival in severe experimental pancreatitis. Ann Surg 1998;228:670-675.
14. McKay CJ, Curran F, Sharples C, Baxter JN, Imrie CW. Prospective placebo-controlled randomized trial of lexipafant in predicted severe acute panreatitis. Br J Surg 1997;84:1239-1243.
15. Raschak M, Unger L, Riechers H, Klinge D. Receptor selectively of endothelin antagonists and prevention of vasoconstriction and endodielin-induced sudden death. J Cardiovasc Pharmacol 1995;26(Suppl 3):S397-S399.
16. Kirchengast M. In Knoll Investigator's Brochure LU 135252. Ludwigshafen, Germany, 1997, pp 16-47.
17. Heuer HO. Pharmacology of heterozepines as PAF-antagonists. In Braquet P, ed. Handbook of PAF and PAF Antagonists. Boca Raton, Fla.: CRC Press, 1990, pp 171-202.
18. Casals-Stenzel J, Heuer HO. Use of WEB 2086 and WEB 2170 as platelet-activating factor (PAF) antagonists. Methods Enzymol 1990;187:455-465.
19. Hurley PR, Cook A, Jehanli A, Austen BM, Hermon-Taylor J. Development of radioimmunoassays for free tetra-1-aspartyl-L-lysine trypsinogen activation peptides (TAP). J Immunol Methods 1988;111:195-203.
20. Mithöfer K, Schmidt J, Gebhard MM, Buhr HJ, Herfarth C, Klar E. Measurement of blood flow in pancreatic exchange capillaries with FITC-labelled erythrocytes. Microvasc Res 1995;49:33-48.
21. Hotz HG, Schmidt J, Ryschich EW, Foitzik T, Buhr HJ, Warshaw AL, Herfarth H, Klar E. Isovolemic hemodilution with dextran prevents contrast medium induced impairment of pancreatic microcirculation in necrotizing pancreatitis in the rat. Am J Surg 1995;169:161-166.
22. Niederau C, Crass RA, Silver G, Ferrell LD, Grendell JH. Therapeutic regimes in acute experimental hemorrhagic pancreatitis. Effects of hydration, oxygenation, peritoneal lavage, and a potent protease inhibitor. Gastroenterology 1988;95: 1648-1657.
23. Klar E, Messmer K, Warshaw AL, Herfarth C. Pancreatic ischemia in experimental acute pancreatitis: Mechanism, significance and therapy. Br J Surg 1990;77:1205-1210.
24. Schölmerich J. Interleukins in acute pancreatitis. Scand J Gastroenterol 1996;219 (Suppl 31):37-42.
25. Formela LJ, Wood LM, Whittaker M, Kingsnorth AN. Amelioration of experimental acute pancreatitis with a potent platelet-activating factor antagonist. Br J Surg 1994;81: 1783-1785.
26. Norman J, Franz M, Messina J, Riker A, Fabri PJ, Rosemurgy AS, Gower WR Jr. Interleukin-1 receptor antagonist decreases severity of experimental acute pancreatitis. Surgery 1995;117:648-655.
27. Grewal HP, Mohey el Din A, Gaber L, Kotb M, Gaber AO. Amelioration of the physiologic and biochemical changes of acute pancreatitis using an anti-TNF-alpha polyclonal anti-body. AmJ Surg 1994;167:214-218.
28. Hughes CB, Grewal HP, Gaber LW, Kotb M, Mohey El-din AB, Mann L, Gaber AO. Anti-TNF-a therapy improves survival and ameliorates the pathophysiologic sequelae in acute pancreatitis in the rat. AmJ Surg 1996;171:274-280.
29. Todd KE, Lewis MPN, Gloor B, Lane JS, Ashley SW, Reber HA. An ETa/ETb endothelin antagonist ameliorates systemic inflammation in a murine model of acute hemorrhagic pancreatitis. Surgery 1997;122;443-450.
30. Foitzik T, Faulhaber J, Hotz HG, Kirchengast M, Buhr HJ. Endothelin-1 triggert die Ausbildung der schweren akuten Pankreatitis. Langenbecks Arch Chir Suppl 1 Forumsband 1997;114:749-753.
31. Jancar S, Abdo EE, Sampietre SN, Kwasneiewski FH, Coelho AM, Bonizzia A, Machado MC. Effect of PAF antagonists on cerulein-induced pancreatitis. J Lipid Mediat Cell Signal 1995;11:41-49.
32. Etienne A, Hecquet F, Guilmard C, Soulard C, Braaquet P. Inhibition of rat endotoxin-induced lethality by BN S2021 and BN 5200, compounds with PAF-acether antagonistic effect and protease-inhibitory activity. Int J Tissue Reac 1987;9:19-26.
33. Tenner S, Sica G, Hughes M, Noordhoek E, Feng S, Zinner M, Banks PA. Relationship of necrosis to organ failure in severe acute pancreatitis. Gastroenterology 1997;113:899-903.
34. Dabrowski A, Gabryelewicz A, Chyczewski L. The effect of platelet activating factor antagonist (BN 52021) on acute experimental pancreatitis with reference to muluorgan oxidative stress. Int J Pancreatol 1995;17:173-180.
35. Rivera JA, Werner J, Warshaw AL, Lewandrowski KB, Rattner DW, Fernandez-del Castillo C. Lexipafant fails to improve survival in severe necrotizing pancreatitis in rats. Int J Pancreatol 1998;23:101-106.
36. Koltai M, Hosford D, Guinot P, Esamu A, Braquet P. PAF. A review of its effects, antagonists and possible future clinical implications (Part II). Drugs 1991;42:174-204.
37. Filep JG, Sirois MG, Rousseau A, Fournier A, Sirois P. Effects of endothelin-1 on vascular permeability in the rat: Interactions with platelet-activating factor. Br J Pharmacol 1991;104: 797-804.
38. Haller H. Endothelial function. General considerations. Drugs 1997;53(Suppl 1):1-10.
39. Foitzik T, Klar E, Buhr HJ. Umsetzung experimenteller Forschungsergebnisse in der Behandlung der akuten Pankreatitis. Chirurg 1998;69:423-431.